MUFG Americas’s Aerie Pharmaceuticals AERI Stock Holding History

MUFG Americas’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-304	Closed	-$19K	–	808
2018 Q3	$19K	Hold	304	–	–	﹤0.01%	634
2018 Q2	$21K	Hold	304	–	–	﹤0.01%	657
2018 Q1	$16K	Sell	304 -91	-23%	-$5.09K	﹤0.01%	699
2017 Q4	$24K	Hold	395	–	–	﹤0.01%	708
2017 Q3	$19K	Buy	395 +9	+2%	+$491	﹤0.01%	750
2017 Q2	$20K	Hold	386	–	–	﹤0.01%	707
2017 Q1	$18K	Buy	386 +68	+21%	+$3.03K	﹤0.01%	739
2016 Q4	$12K	Sell	318 -62	-16%	-$2.35K	﹤0.01%	815
2016 Q3	$14K	Hold	380	–	–	﹤0.01%	790
2016 Q2	$7K	Buy	380 +225	+145%	+$3.64K	﹤0.01%	951
2016 Q1	$2K	Buy	+155	New	+$2.45K	﹤0.01%	1120

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

MUFG Americas's AERI Position: Q4 2018 in Review

MUFG Americas sold out of Aerie Pharmaceuticals (AERI) in Q4 2018, closing a stake of 304 shares — an estimated $19K sold.

MUFG Americas first reported a position in AERI in Q1 2016 and held it in 11 quarters. The position peaked at $24K in Q4 2017. 160 funds tracked by Wall St. Rank hold AERI as of Q4 2018.

MUFG Americas reported no remaining Aerie Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
MUFG Americas sold 304 Aerie Pharmaceuticals shares in Q4 2018, an estimated $19K.
MUFG Americas first reported a position in Aerie Pharmaceuticals in Q1 2016 and held it in 11 quarters.
MUFG Americas's Aerie Pharmaceuticals position peaked at $24K in Q4 2017.
160 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2018.

Based on MUFG Americas's 13F filing for Q4 2018, filed 13 Feb 2019.